NEW YORK (GenomeWeb) –Oxford Immunotec has sued Qiagen, Quest Diagnostics, and Laboratory Corporation of America for infringing patents underlying Oxford's T-SPOT TB test.

In a complaint filed this week in US District Court for the District of Massachusetts, Oxford alleged that Qiagen's QuantiFERON-TB Gold and QuantiFERON-TB Plus tuberculosis diagnostics use peptide antigens patented by Oxford.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.